DeepSeek Selloff Panic Overstated for US AI Giants WSJ Analysis Finds US Productivity Growth Slows in Q4 While Labor Costs Rise at Faster Pace Bo Bichettes Adjustment Challenges With Mets May Shape Teams Season Outlook OpenAIs IPO Plans Could Mark Landmark Market Debut Equinix Stock Outlook Wall Street Sentiment Reflects Cautious Optimism on Data Center Demand US Jobless Claims Remain at Low Levels Signaling Labor Market Resilience CrossAmerica Partners LP CAPL Q1 2026 Earnings Strong Earnings Surprise Offsets Missing Revenue Data TPST Q1 2026 Earnings Significant EPS Miss Amid No Revenue Stock Gains 276 EVGO Q1 2026 Earnings NarrowerThanExpected Loss Despite Limited Revenue Disclosure Trinity Capital Inc TRIN Q1 2026 Earnings EPS Beats Estimates by 116 MHLA Q3 2024 Earnings Underlying Company Reports Negative EPS No Revenue Data Available PAR Technology Q1 2026 Earnings EPS Surges Past Estimates Stock Moves Higher Galata Acquisition Corp II LATA Holds Steady Near 1005 SPAC Trading in Neutral Territory Allegro MicroSystems ALGM Rallies 28 Testing Key Resistance Amid Renewed Momentum Xos Inc XOS Holds Steady at 210 Key Support and Resistance in Focus 4D Molecular Therapeutics FDMT Surges 310 Biotech Momentum Builds Eaton Vance Diversified Equity Income Fund ETY Slightly Lower as IncomeFocused Investors Weigh Rate Outlook Major Tech Companies Establish 125 Million Semiconductor Research Center at UCLA Lyft Q1 2026 Earnings Narrow Earnings Miss as Shares Edge Higher National CineMedia NCMI Holds Steady Near Support Amid Modest Decline Bitcoin Price Plunges Amid USIran Tensions and ETF Outflows Forbes Ranks Top 10 Cryptocurrencies for May 26 2026 Adani Enterprises Among Stocks Hitting 52Week Highs Rallying Up to 30 in a Month Marvell Technology Shares Dip Despite Strong AI Demand and Upbeat Growth Forecast Walmart May Use Tariff Refunds to Lower Prices Amid Consumer Stress Dollar Holds Near SixWeek High as Geopolitical Tensions Over Iran Stir Demand for Safe Havens Immunic Appoints Erik Lundgren as CEO Amid Phase 3 Multiple Sclerosis Trial Progress